Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Leone

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
North Carolina Medical Journal|January 6, 2007
Responding with treatment to those acutely infected with HIV: no time to losePeter Leone
Current Infectious Disease Reports|March 19, 2003
Type-specific Serologic Testing for Herpes Simplex Virus-2Peter Leone
Herpes : the Journal of the IHMF|June 16, 2005
Expert commentary: genital herpes transmissionPeter Leone
Medical Economics|April 3, 2012
Malpractice policies: 5 ways a broker or agent can help. A professional who understands the market could be well-suited to finding a policy that meets your needsPeter Leone
Current Medical Research and Opinion|October 22, 2005
Reducing the risk of transmitting genital herpes: advances in understanding and therapyPeter Leone
The Journal of Infectious Diseases|June 3, 2006
Time to translate new knowledge into practice: a call for a national genital herpes control programEdward W Hook, Peter Leone
Sexually Transmitted Diseases|December 21, 2011
Utility of episodic acyclovir therapy for HSV-2 in AfricaArlene C Sena, Peter Leone
Sexually Transmitted Diseases|June 1, 2007
Famciclovir reduces viral mucosal shedding in HSV-seropositive personsPeter Leone, Terri Warren, Kamal Hamed, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 2, 2009
Number of named partners and number of partners newly diagnosed with HIV infection identified by persons with acute versus established HIV infectionZack S Moore, Sandi McCoy, Joann Kuruc, et al.
Current Medical Research and Opinion|January 15, 2010
One-day famciclovir vs. placebo in patient-initiated episodic treatment of recurrent genital herpes in immunocompetent Black patientsPeter Leone, Mohamed Abudalu, Essack Mitha, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
North Carolina Medical Journal|January 6, 2007
Responding with treatment to those acutely infected with HIV: no time to losePeter Leone
Current Infectious Disease Reports|March 19, 2003
Type-specific Serologic Testing for Herpes Simplex Virus-2Peter Leone
Herpes : the Journal of the IHMF|June 16, 2005
Expert commentary: genital herpes transmissionPeter Leone
Medical Economics|April 3, 2012
Malpractice policies: 5 ways a broker or agent can help. A professional who understands the market could be well-suited to finding a policy that meets your needsPeter Leone
Current Medical Research and Opinion|October 22, 2005
Reducing the risk of transmitting genital herpes: advances in understanding and therapyPeter Leone
The Journal of Infectious Diseases|June 3, 2006
Time to translate new knowledge into practice: a call for a national genital herpes control programEdward W Hook, Peter Leone
Sexually Transmitted Diseases|December 21, 2011
Utility of episodic acyclovir therapy for HSV-2 in AfricaArlene C Sena, Peter Leone
Sexually Transmitted Diseases|June 1, 2007
Famciclovir reduces viral mucosal shedding in HSV-seropositive personsPeter Leone, Terri Warren, Kamal Hamed, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 2, 2009
Number of named partners and number of partners newly diagnosed with HIV infection identified by persons with acute versus established HIV infectionZack S Moore, Sandi McCoy, Joann Kuruc, et al.
Current Medical Research and Opinion|January 15, 2010
One-day famciclovir vs. placebo in patient-initiated episodic treatment of recurrent genital herpes in immunocompetent Black patientsPeter Leone, Mohamed Abudalu, Essack Mitha, et al.
Pageof 3